European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis.
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets.
Script Assist, the SaaS platform now used by some of the UK’s leading medical cannabis clinics and prescribing doctors, is set to launch a major ground-up overhaul of its platform.
Accounts receivable (AR) are ballooning to unsustainable levels, and beyond a few informal “blacklisted” groups on social media, no one is talking about the financial chokehold this is putting on the supply chain.
Last month, one of the first cannabis entrants onto the London Stock Exchange, Oxford Cannabinoid Technologies, announced plans to depart the public market, citing numerous issues with the UK’s current landscape.
The development will help to reduce costs for medical cannabis patients.
C-END is utilising blockchain technology to solve problems in the cannabis industry with tracking, tracing, authenticity and trust.
THE confluence of hundreds of cannabis industry professionals from over 30 countries at this year’s Cannabis Europa London saw a recurring talking point emerge, the need for a global standardised model for the regulation of cannabis.